Osteoporosis fracture in menopausal women: Alendronate reduces the risk;Fracture ostéoporotique chez les femmes ménopausées: L'alendronate réduit le risque

Revue Medicale Suisse

Volumn 4, Issue 183, 2008, Pages 2703-

  Burnand, B ^c   Bize, R ^a   Peytremann Bridevaux, I ^a   Walther, M Rège ^c   Lamy, Oliver ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE;

BONE DENSITOMETRY; FRAGILITY FRACTURE; HUMAN; MENOPAUSE; MORBIDITY; MORTALITY; PRIMARY PREVENTION; SECONDARY PREVENTION; SHORT SURVEY; VERTEBRA FRACTURE;

ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; FEMALE; FRACTURES, BONE; HIP FRACTURES; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PRIMARY PREVENTION; RISK FACTORS; SECONDARY PREVENTION; SPINAL FRACTURES;

EID: 59249089373     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (0)